Page 164 - Read Online
P. 164
Page 6 of 7 Strokova et al. Vessel Plus 2019;3:16 I http://dx.doi.org/10.20517/2574-1209.2019.08
Availability of data and materials
Authors confirm that the data were strictly obtained from medical records according to the privacy policy
and ethics code of our institute.
Financial support and sponsorship
Research work carried out at the expense of subsidies for public tasks in the framework of the Program of
Basic Research of state academies of science for 2013-2020 (0529-2016-0007; 0529-2018-0113).
Conflicts of interest
All authors declared that there are no conflicts of interest.
Ethical approval and consent to participate
The study received an approval from the Local Ethic Committee (0529-2016-0007), as it was conducted
as a part of the State Program of Basic Research. All procedures were done with accordance to GCP
standards and Informed consents from parents or official representatives were received prior to any research
procedures.
Consent for publication
Not applicable.
Copyright
© The Author(s) 2019.
REFERENCES
1. Ozen H. Glycogen storage diseases: new perspectives. World J Gastroenterol 2007;13:2541-53.
2. Bhattacharya K. Investigation and management of the hepatic glycogen storage diseases. Transl Pediatr 2015;4:240-8.
3. Moses SW, Wanderman KL, Myroz A, Frydman M. Cardiac involvement in glycogen storage disease type III. Eur J Pediatr
1989;148:764-6.
4. Tada H, Kurita T, Ohe T, Shimomura K, Ishihara T, et al. Glycogen storage disease type III associated with ventricular tachycardia. Am
Heart J 1995;130:911-2.
5. Humbert M, Labrune PH, Simonneau G. Severe pulmonary arterial hypertension in type 1 glycogen storage disease. Eur J Pediatr
2002;161:S93-6.
6. Humbert M, Labrune P, Sitbon O, Le Gall C, Callebert J, et al. Pulmonary arterial hypertension and type-I glycogen-storage disease: the
serotonin hypothesis. Eur Respir J 2002;20:59-65.
7. Derks TG, van Rijn M. Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring of dietary management and future
directions. J Inherit Metab Dis 2015;38:537-43.
8. Rake JP, Visser G, Labrune P, Leonard P, Ullrich K, et al. Glycogen storage disease type I: diagnosis, management, clinical course and
outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 2002;161:S20-S34.
9. Greenea HL, Swift LL, Knapp HR. Hyperlipidemia and fatty acid composition in patients treated for type IA glycogen storage disease. J
Pediatr 1991;119:398-403.
10. Fernandes J, Alaupovic P, Wit JM. Gastric drip feeding in patients with glycogen storage disease type I: its effects on growth and plasma
lipids and apolipoproteins. Pediatr Res 1989;25:327-31.
11. Bandsma RH, Smit GP, Kuipers F. Disturbed lipid metabolism in glycogen storage disease type 1. Eur J Pediatr 2002;161:S65-9.
12. Bandsma RH, Prinsen BH, van Der Velden Mde S, Rake JP, Boer T, et al. Increased de novo lipogenesis and delayed conversion of
large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a. Pediatr Res
2008;63:702-7.
13. Sever S, Weinstein DA, Wolfsdorf J, Gedik R, Schaefer EJ. Glycogen storage disease type 1a: linkage of glucose, glycogen, lactic acid,
triglyceride, and uric acid metabolism. J Clin Lipidol 2012;6:596-600.
14. Carvalho PM, Silva NJ, Dias PG. Glycogen storage disease type 1a - a secondary cause for hyperlipidemia: report of five cases. J
Diabetes Metab Disord 2013;12:25.
15. Bernier AV, Sentner CP, Correia CE, Theriaque DW, Shuster JJ, et al. Hyperlipidemia in glycogen storage disease type III: effect of age
and metabolic control. J Inherit Metab Dis 2008;31:729-32.
16. Zhang PY, Xu X, Li XC. Cardiovascular diseases: oxidative damage and antioxidant protection. Eur Rev Med Pharmacol Sci
2014;18:3091-6.
17. Wittensteina B, Kleina M, Finckha B, Ullrich K, Kohlschütter A. Plasma antioxidants in pediatric patients with glycogen storage
disease, diabetes mellitus, and hypercholesterolemia. Free Radic Biol Med 2002;33:103-10.
18. Bernier AV, Correia CE, Haller MJ, Theriaque DW, Shuster JJ, et al. Vascular dysfunction in glycogen storage disease type I. J Pediatr
2009;154:588-91.